Lisata Therapeutics

LSTA

Market cap $20M

LSTA Hedge Fund Activity: Q1 2026 in Review

34 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in Lisata Therapeutics (LSTA) for Q1 2026, worth a combined $5.27M — up 288% from $1.36M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new LSTA positions and 4 closed out — a net gain of 10 holders — while 5 added to existing stakes and 3 trimmed.

The largest buyer was Deltec Asset Management, opening a new position worth an estimated $372K. The largest seller was BML Capital Management, exiting entirely with an estimated $136K sold.

• 34 institutional investors held Lisata Therapeutics (LSTA) as of Q1 2026, up from 25 in Q4 2025.
• Funds reported $5.27M of Lisata Therapeutics stock for Q1 2026, up 288% quarter-over-quarter.
• 14 funds opened new Lisata Therapeutics positions in Q1 2026 and 4 closed out, a net change of +10 holders.
• The largest Lisata Therapeutics buyer in Q1 2026 was Deltec Asset Management, an estimated $372K added.
• The largest Lisata Therapeutics seller in Q1 2026 was BML Capital Management, an estimated $136K sold.

Based on aggregated 13F filings for Q1 2026.